---
category: news
title: "Astellas and Dyno Therapeutics to develop AAV gene therapy vectors"
excerpt: "Astellas Pharma has signed an option and licence agreement with Dyno Therapeutics to develop next-generation adeno-associated virus (AAV) The gene therapy vectors will be developed using Dyno Therapeuticsâ€™ CapsidMap platform,"
publishedDateTime: 2021-12-02T15:39:00Z
originalUrl: "https://www.pharmaceutical-technology.com/news/astellas-dyno-aav-gene-therapy-vectors/"
webUrl: "https://www.pharmaceutical-technology.com/news/astellas-dyno-aav-gene-therapy-vectors/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: Pharmaceutical Technology
  domain: pharmaceutical-technology.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/10/2021/12/23103442409_57067b9513_k.jpg"
    width: 1920
    height: 1200
    isCached: true

related:
  - title: "Dyno attracts $1.6bn gene therapy deal with Astellas"
    excerpt: "Astellas has signed another bolt-on deal to build its gene therapy pipeline, agreeing a deal with Dyno Therapeutics"
    publishedDateTime: 2021-12-02T09:09:00Z
    webUrl: "https://pharmaphorum.com/news/dyno-attracts-1-6bn-gene-therapy-deal-with-astellas/"
    type: article
    provider:
      name: pharmaphorum.com
      domain: pharmaphorum.com
    quality: 39
    images:
      - url: "https://pharmaphorum.com/wp-content/uploads/2018/12/wednesday-image.jpg"
        width: 1200
        height: 675
        isCached: true

secured: "Od5eehBfOOgNA20XEBSaD+1251xT2U73syTctYYiBfC0Az31QP4HlfMzrm8/+TQi2WQxgJgUbZhxMIA7Tk6oUC7NirvJkPS55r0oIaXr9fpvEC1PsouIziKZPdAzOFUkwb8tHpIMiuOJU9c5LGYioVSkZfmhP6fCPvaZtMJjGPMu7Sp2krgGJEaEKrrJpXJM6AgxKorLD+WNrTb1vAbiPVFR4cBYDBFOr3A2SDLOrxN4YSyXRw9ty4P/oQ/R6OxGh9etKN30Sy6c1JNznU7IHSyB6dsBHVYn2GsGhvdJ9jdADZtt1AZZ/CTZx9oEB/6A1pP/QD+lT+8Wj93HvSY2IPN1Fv6YBlCLTWKiZ0/scvc=;E6P5+q4CMrQr8+5N9sMj4A=="
---

